FCM
KYNB

Flinton Capital Management’s Kyntra Bio KYNB Stock Holding History

Flinton Capital Management’s Portfolio KYNB Stock Details KYNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-34
Closed -$46K – 885
2019
Q1 		$46K Sell
34
-4
-11% -$5.42K ﹤0.01% 820
2018
Q4 		$44K Buy
+38
New +$42.7K ﹤0.01% 804

Other funds holding KYNB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Flinton Capital Management's KYNB Position: Q2 2019 in Review

Flinton Capital Management sold out of Kyntra Bio (KYNB) in Q2 2019, closing a stake of 34 shares — an estimated $46K sold.

Flinton Capital Management first reported a position in KYNB in Q4 2018 and held it in 2 quarters. The position peaked at $46K in Q1 2019. 190 funds tracked by Wall St. Rank hold KYNB as of Q2 2019.

  • Flinton Capital Management reported no remaining Kyntra Bio position as of Q2 2019 after selling out during the quarter.
  • Flinton Capital Management sold 34 Kyntra Bio shares in Q2 2019, an estimated $46K.
  • Flinton Capital Management first reported a position in Kyntra Bio in Q4 2018 and held it in 2 quarters.
  • Flinton Capital Management's Kyntra Bio position peaked at $46K in Q1 2019.
  • 190 funds tracked by Wall St. Rank held Kyntra Bio as of Q2 2019.

Based on Flinton Capital Management's 13F filing for Q2 2019, filed 13 Aug 2019.